Feb 6, 2024

Robert Maxwell, Founder and CEO of ClinConnect, has created a platform that simplifies the process of patients finding clinical trials, shortens enrollment times, and focuses on providing support to ensure patient retention in the trials. The platform works in collaboration with sponsors, healthcare providers, hospitals, and other stakeholders to streamline communication and more quickly identify qualified clinical trial participants from a broader universe.

Robert explains, "We make the process of not only finding the trial very, very simple, but we also shorten the enrollment times, which in the case of acute disease is distinctly important. But generally speaking, it's usually more advantageous to get into a trial more quickly than waiting unnecessarily. And so, while we don't claim to solve all clinical trial recruitment issues, we've found that our patients generally see about a 60% to 70% reduction in enrollment time by working with us and letting us be their advocate through the enrollment process."

"On the flip side, with pharmaceutical companies who are sponsoring these trials or running them directly, 70% of trials don't meet their recruitment targets. And that's profoundly problematic for them."

"So, we do not just work with the patient to get them into the trial. We will continue to advocate for them. And as we use the term, we'll hold their hand through the entire trial process. Then, we even have some post-trial services and some work we do with them after the trial. So we have found that because we don't just work with them in one kind of component of the life cycle of the trial, our retention rates are much higher as well. "

#ClinConnect #ClinicalTrials #TrialRetention #TrialRecruitment #DigitalHealth #PatientAdvocacy

clinconnect.io

Listen to the podcast here